Skip to content
Middletown Life
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
Trevi Therapeutics, Inc.
Trevi Therapeutics Announces Closing of $173 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
April 20, 2026
Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock
April 16, 2026
Trevi Therapeutics Announces Proposed Public Offering of Common Stock
April 16, 2026
Trevi Therapeutics to Participate in Upcoming Events
April 1, 2026
Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates
March 17, 2026
Trevi Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results and Provide Business Updates on March 17, 2026
March 10, 2026
Trevi Therapeutics to Participate in Upcoming March Conferences
March 2, 2026
←
Previous Page
1
2